Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study. by Tomas Kalincik, Manuela Vaneckova, Michaela Tyblova, Jan Krasensky, Zdenek Seidl, Eva Havrdova, Dana Horakova

Get full text

MRI correlates of disability progression in patients with CIS over 48 months by Tomas Uher, Dana Horakova, Niels Bergsland, Michaela Tyblova, Deepa P. Ramasamy, Zdenek Seidl, Manuela Vaneckova, Jan Krasensky, Eva Havrdova, Robert Zivadinov

Get full text

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study by Niels Bergsland, Dana Horakova, Michael G. Dwyer, Tomas Uher, Manuela Vaneckova, Michaela Tyblova, Zdenek Seidl, Jan Krasensky, Eva Havrdova, Robert Zivadinov

Get full text

Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients by Tomas Uher, Kelly Fellows, Dana Horakova, Robert Zivadinov, Manuela Vaneckova, Lukas Sobisek, Michaela Tyblova, Zdenek Seidl, Jan Krasensky, Niels Bergsland, Bianca Weinstock-Guttman, Eva Havrdova, Murali Ramanathan

Get full text

Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients by Kelly Fellows, Tomas Uher, Richard W. Browne, Bianca Weinstock-Guttman, Dana Horakova, Helena Posova, Manuela Vaneckova, Zdenek Seidl, Jan Krasensky, Michaela Tyblova, Eva Havrdova, Robert Zivadinov, Murali Ramanathan

Get full text

Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study. by Dana Horakova, Robert Zivadinov, Bianca Weinstock-Guttman, Eva Havrdova, Jun Qu, Miriam Tamaño-Blanco, Darlene Badgett, Michaela Tyblova, Niels Bergsland, Sara Hussein, Laura Willis, Jan Krasensky, Manuela Vaneckova, Zdenek Seidl, Petra Lelkova, Michael G Dwyer, Ming Zhang, Haoying Yu, Xiaotao Duan, Tomas Kalincik, Murali Ramanathan

Get full text